10-Sep-2010 - Chiral Technologies Europe SAS

Chiral Technologies Europe Signs Licensing Agreement with the University of Vienna

Chiral Technologies Europe (CTE) announced that it has entered into an exclusive worldwide licensing agreement with the University of Vienna, Austria. According to the agreement, CTE acquired exclusive manufacturing and marketing rights for novel Cinchona alkaloid-based zwitterion-exchange type chiral stationary phases (CSPs), invented and developed by researchers at the University of Vienna. The addition of the new CSPs provides a significant expansion of Chiral Technologies’ well-established portfolio of enantioselective chromatography products.

“The opportunity to collaborate with Professor Lindner and his renowned research team at the University of Vienna on the commercialization of this new stationary phase fits nicely within our broader strategy to expand our position in supplying new chirality tools to the life science industry,” said Dieter Heckmann, President and CEO of CTE. “This licensing agreement demonstrates our continued commitment to deliver the best solutions to the global market.”

The zwitterion-exchange type CSPs separate a broad range of ionizable chiral analytes, ranging from acidic and basic molecules to zwitterionic molecules that bear basic and acidic moieties in the same molecule. It has been adapted for direct enantiomer resolution of natural and synthetic free a-, b-, g-amino acids without requiring pre-column derivatization. In addition, chiral zwitterionic peptides and peptomimetics can be separated into their respective stereoisomers. The new selectors can be used in liquid chromatography and supercritical fluid chromatography modes with mobile phases that are compatible with all LC/MS applications.

Facts, background information, dossiers
More about Chiral Technologies
  • News

    Chiral Technologies Europe Signs Distribution Agreement with Hichrom

    Chiral Technologies Europe announced it has signed a non-exclusive distribution agreement with Hichrom Ltd. to better serve its customers in the United Kingdom. "We are pleased to formalise our relationship with Hichrom. The technical sales group of Hichrom are well placed to present the b ... more

    Chiral Technologies Europe Acquires ChromTech Ltd. of U.K.

    Chiral Technologies Europe (CTE), a wholly owned subsidiary of DAICEL Chemical Industries, Ltd, announced the acquisition of ChromTech Ltd, of Congleton, U.K. According to the company, the two companies’ combined product lines of enantioselective chromatography columns will provide a powe ... more

    Daicel Chemical Industries and Groupe Novasep SAS form a strategic co-operation

    Daicel Chemical Industries, Ltd. and Groupe Novasep SAS, announce the formation of a strategic technical co-operation aimed at streamlining the use of chiral chromatography to manufacture late-stage clinical and commercial chiral intermediates and APIs. Under the terms of the agreement, th ... more

  • Companies

    Chiral Technologies Europe SAS

    CTE specializes in enantiomeric separation products and services for the pharmaceutical, bio technical and related industries. The company assists customers from initial analysis to production of the finished product. CTE is a wholly owned subsidiary of the Japanese fine chemical producer, ... more

    Chiral Technologies, Inc.

    CHIRAL TECHNOLOGIES is the leading supplier of chiral chromatography products and services in North and South America. To maintain our leadership, we continually create new technologies, products, and services, and provide excellent support to meet the rapidly growing needs of our customers ... more

More about Universität Wien